There is growing recognition that involving patients in the development of new patient-reported outcome measures helps ensure that the outcomes that matter most to people living with health conditions are captured. Here, we describe and discuss different experiences of integrating patients as full patient research partners (PRPs) in outcomes research from multiple perspectives (e.g., researcher...

The most contentious, unresolved issue in biomedicine in the last twenty-five years has been how to best address compensated partnerships between academic researchers and the pharmaceutical industry. Law and policy deliberately promote these partnerships through intellectual property law, research funding programs, and drug and device approval pathways while simultaneously condemning them throu...

Prior research in the context of public private partnerships has mainly focused on organizational and risk management aspects. Because there is a growing number of IT megaprojects in the context of public private partnerships, recent work concentrates on the explanation of the relationship between public and private partners and the success factors for these relations. However, we still have a ...

politics is not the ghost in the machine of global health policy. conceptually, it makes little sense to argue otherwise, while history is replete with examples of individuals and movements engaging politically in global health policy. were one looking for ghosts, a more likely candidate would be democracy, which is currently under attack by a new global health technocracy. civil society moveme...

Harnessing the unprecedented flexibility that iPSC technology and gene editing offer academic and industry-based researchers requires developing an interactive model of collaboration. Such a model will have to leverage the basic research expertise in academia with the pharmaceutical industry's knowledge in manufacturing and high throughput technology to be successful.

Public sector organisations are increasingly becoming aware of the need to harness the innovative capacity of their employees. In the UK many public sector research institutes have put in place processes to increase the speed at which new technological innovations are exploited and commercialised. These types of initiatives have also been implemented into public sector service organisations. Fo...

This article addresses the growing interest among U.S. scientific organizations and federal funding agencies in strengthening research partnerships between American universities and the private sector. It outlines how core facilities at universities can contribute to this partnership by offering services and access to high-end instrumentation to both nonprofit organizations and commercial organ...